Current Opinion in Endocrinology Diabetes and Obesity

Papers
(The TQCC of Current Opinion in Endocrinology Diabetes and Obesity is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Obesity as a risk factor for thyroid cancer45
Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome45
Hashimoto's thyroiditis as a risk factor for thyroid cancer40
The role of beta-cell dysfunction in early type 1 diabetes39
Gut peptides and the microbiome: focus on ghrelin39
The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis37
Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes31
Ketogenic diet as a metabolic treatment for mental illness28
Endocrine-disrupting chemicals and breastfeeding duration: a review26
Expert position statements: comparison of recommendations for the care of adults and youth with elevated lipoprotein(a)22
Telehealth in type 1 diabetes21
Multimodal imaging of thyroid cancer21
Genetics of pheochromocytoma and paraganglioma21
HDL functionality in type 1 and type 2 diabetes: new insights21
Continuous glucose monitoring in the hospital: an update in the era of COVID-1920
Low carbohydrate diet: are concerns with saturated fat, lipids, and cardiovascular disease risk justified?20
Use of artificial intelligence and machine learning for estimating malignancy risk of thyroid nodules19
Pharmacotherapy in pediatric obesity: current evidence and landscape19
Plant-based diets and bone health: sorting through the evidence19
Endotypes in T1D: B lymphocytes and early onset18
Low carbohydrate ketogenic therapy as a metabolic treatment for binge eating and ultraprocessed food addiction18
Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real?18
Adult obesity and its complications: a pediatric disease?18
Hypogonadism and metabolic syndrome: review and update17
Renal function in patients following a low carbohydrate diet for type 2 diabetes: a review of the literature and analysis of routine clinical data from a primary care service over 7 years17
Using a low-carbohydrate diet to treat obesity and type 2 diabetes mellitus17
Growth, body composition, and endocrine issues in Williams syndrome16
Pediatric adrenocortical tumor – review and management update16
Thermal ablation in adrenal disorders: a discussion of the technology, the clinical evidence and the future16
Long-acting amylin analogues for the management of obesity16
Lipid management for cardiovascular risk reduction in type 1 diabetes15
Medullary thyroid carcinoma14
Gut-derived serotonin and its emerging roles in immune function, inflammation, metabolism and the gut–brain axis14
Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide [Part 1]: biology, pharmacology, and new insights into their cellular basis of action/signaling which are providing new14
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease14
Type 2 diabetes mellitus and cognitive function: understanding the connections13
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia13
Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity13
Lipoprotein (a) and diabetes mellitus: causes and consequences13
Menstrual cycle length and modern living: a review13
Patient perception of receiving a thyroid cancer diagnosis12
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes12
Survival benefit of endocrine dysfunction following immune checkpoint inhibitors for nonthyroidal cancers12
Advances in newer basal and bolus insulins: impact on type 1 diabetes12
The biochemistry of low-carbohydrate and ketogenic diets12
Insulin resistance and skeletal health12
Advanced glycation endproducts and bone quality: practical implications for people with type 2 diabetes11
Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma10
Dyslipidemia in childhood and adolescence: from screening to management10
Current state of antigen-specific immunotherapy for type 1 diabetes10
Health effects of androgen abuse: a review of the HAARLEM study10
Androgen abuse and the brain10
Clinical outcomes in 21-hydroxylase deficiency10
Gastrointestinal hormones and regulation of gastric emptying10
Effect of low carbohydrate diets on insulin resistance and the metabolic syndrome10
The female athlete triad: review of current literature10
Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management9
Effects of marijuana on reproductive health: preconception and gestational effects9
Lipidomics in diabetes9
Alternative routes of levothyroxine administration for hypothyroidism9
Enterohormone therapy for short bowel syndrome9
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and thyroid disease. An update9
Effects of diabetes on osteocytes9
The uncommon forms of congenital adrenal hyperplasia9
Ghrelin-cell physiology and role in the gastrointestinal tract8
The role of endocrine-disrupting phthalates and bisphenols in cardiometabolic disease: the evidence is mounting8
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare8
A short history of saturated fat: the making and unmaking of a scientific consensus8
Can a carnivore diet provide all essential nutrients?8
Apolipoprotein B: the Rosetta Stone of lipidology8
Functional imaging in ectopic Cushing syndrome8
Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide (Part 2): biology and clinical importance in central nervous system and inflammatory disorders8
An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture8
The potential of a ketogenic diet to minimize effects of the metabolic fault in glycogen storage disease V and VII7
Appropriate selection of candidates for outpatient thyroidectomy7
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?7
Adverse events associated with immune checkpoint inhibitors: a new era in autoimmune diabetes7
The therapeutic properties of ketogenic diets, slow-wave sleep, and circadian synchrony7
Current and future treatment options for adrenal insufficiency7
Applying implementation science to improve care for familial hypercholesterolemia7
Environmental toxicant exposure and menstrual cycle length7
Cancer incidence and mortality following treatment of hyperthyroidism with radioactive iodine7
Chemosensing in enteroendocrine cells: mechanisms and therapeutic opportunities7
Advanced imaging and theranostics in thyroid cancer7
Pharmacological therapies to address obesity in type 1 diabetes7
Reversal of severe hypertriglyceridemia with intermittent fasting and a very-low-carbohydrate ketogenic diet: a case series7
Mass cytometry and type 1 diabetes research in the age of single-cell data science7
Are diabetes microvascular complications risk factors for fragility fracture?7
Differences in the management of thyroid nodules in children and adolescents as compared to adults7
0.021251201629639